Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2131 (LINC02131)

Target
LINC02131
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02131 (Long intergenic non-protein coding RNA 2131) is a human gene that encodes a long intergenic non-coding RNA (lincRNA) molecule[1][5]. LincRNAs are a subset of long non-coding RNAs (lncRNAs) defined by their position outside of known protein-coding gene regions, with lengths exceeding 200 nucleotides[3][9]. They are widely transcribed in the genome, although only a minority have defined molecular or cellular functions. Most lincRNAs (including LINC02131) are believed to regulate chromatin structure, gene expression, or post-transcriptional processes, often in a tissue- or context-specific manner. While some lincRNAs are implicated in disease pathogenesis or cellular differentiation, the specific biological role and relevance to human disease of LINC02131 remains uncharacterized in current literature. No drugs target it and it does not appear in current clinical or translational research as a biomarker or therapeutic target[1][5][3].

Other names
LINC02131Long intergenic non-protein coding RNA 2131
02

Mechanism of action

None known. No mechanisms established for drugs as there are no known drug interactions.

03

Biological functions

Unknown for LINC02131 specificallyLong intergenic non-coding RNAs (lincRNAs), in general: Regulation of gene expression (transcriptional, post-transcriptional, chromatin remodeling)Scaffolding of protein complexesRNA stabilizationModulation of mRNA translation and decayInfluencing nuclear architecture
04

Disease associations

Unknown for LINC02131 specificallyLincRNAs in general have been implicated in: CancerDevelopmental disordersOther diseases, depending on context and lincRNA studied
05

Safety considerations

None reported for LINC02131, and this entity is not currently considered a drug target.
06

Interacting drugs

None known
07

Biomarkers

None established for LINC02131

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2131 (LINC02131).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2131 (LINC02131).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call